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Abstract: Direct Agglutination Test (DAT) and rK39 strip tests have been considered
useful for the diagnosis of Visceral Leishmaniasis (VL). DAT with aqueous (AQ) antigen has
drawbacks like limited stability and requirement of uninterrupted cold chain till its end use.
The present study describes the development of modified DAT based on freeze-dried (FD)
antigen from L. donovani promastigotes. FD antigen was found to be stable for 24 months at
56℃. FD antigen, AQ antigen and rK39 strips were evaluated with 708 serum samples of
different disease spectrum of VL. Findings revealed that both FD as well as AQ antigen
showed 96.5% sensitivity and 100% specificity, where as rK39 strip test exhibited 86%
sensitivity and 100% specificity. Statistically the performance of FD and AQ antigen was
better than rK39 (P<0.05) in Indian VL patients. It also appeared that the production of
large batches of FD antigen might be highly commercially viable and economically feasible
for the diagnosis of VL in millions of poverty ridden endemic population under adverse field
conditions.
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INTRODUCTION
VL is caused by protozoan parasites of L. donovani complex. It is geographically dis-
tributed in tropical and subtropical regions of the world. The disease is often fatal if not
diagnosed timely and left untreated. The occurrence of disastrous VL epidemics in several
regions of world in the past has created a pressing demand for appropriate diagnostic tools.
Its definitive diagnosis requires a high order of sensitivity, specificity, cost effectiveness and
field utility of various methods and techniques. Pathological methods are mainly based on
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demonstration of parasites in biopsies or aspirates from infected spleen, bone marrow and
lymphnodes (Zijlstra et al, 1992). Their sensitivities are in the range of 90-95% (Manson Bahr
1987; 1988; Zijlstra et al, 1992,). These procedures are invasive, troublesome and are not
conveniently applicable under field conditions (Osman, 1998). They have also often resulted in
deaths of clinical suspects (Boelaert et al, 1983; 1999; Thakur, 1997). A venous or capillary
blood sample is, therefore, more acceptable. PCR amplification testing for Leishmanial DNA
is also highly sensitive and specific but its field applicability has not yet been established
(Meredith et al, 1995).
An ideal immuno-diagnostic test should be simple, quick, cost effective, highly sensitive
and specific and be applicable in the fields even in the adverse conditions that prevail in
many areas where Leishmaniasis is endemic. Several serological tests has been reported for
the diagnosis of VL (Osman, 1998), of which direct agglutination test (DAT) (Harith et al,
1986) and rK39 dipstick, which is based on ELISA with rK39 recombinant protein having a
39 amino acid repeat, that is a part of a 230 kDa kinesin related protein predominant in L.
chagasi tissue amastigotes (Sundar et al, 1998; Zijlstra et al, 1998), are promising in meeting
these requirements.
DAT makes use of aqueous (AQ) antigen prepared from L. donovoani promastiogotes. It
is associated with major drawbacks like, limited stability and requirement of uninterrupted
cold chain during its storage and transportation. The shaking during transportation also sig-
nificantly affects the reproducibility of results with AQ antigen. To overcome these draw-
backs, Meredith and co-workers (1995) first reported use of stable freeze dried (FD) antigen
for sero-diagnosis of VL under field conditions. Subsequently, Oskam et al (1996, 1999),
Zijlstra et al, (1997) and Ozbel et al, (2000) also demonstrated its use in diagnosis of canine
and humanVL. To further explore its field utility, particularly in Indian VL cases, we, in our
laboratory, have independently and indigenously developed FD antigen from L. donovani
(MHOM/IN/80/Dd8). The present study describes comparative diagnostic usefulness of AQ
and FD Antigen and rK39 dipsticks.
MATERIALS AND METHODS
Preparation of the AQ and FD antigen:
The AQ antigen was prepared from promastigotes of L. donovani (MHOM/IN/80k/Dd
8) by the method of Harith et al, (1986,1988) except that the organism was grown in L-15
medium supplemented with 10% Fetal Calf Serum (GIBCO BRL, Grand Island, N.Y.) instead
of RPMI-1640 and in place of counting the promastigotes at each step of antigen preparation
the percent promastigote was determined by microcentrifuge technique. In brief, the
promastigotes were harvested in late log to stationary phase and washed with Locke's solu-
tion. 10% suspension of the promastigotes was treated with equal volume of 0.8% trypsin in
Locke's solution at 37°C for 45 minutes. After washing with Locke's solution 10% suspension
was fixed by treatment with equal volume of 4% (w/v) formaldehyde in Locke's solution for
20 hrs at 4°C followed by washing in cold saline citrate. 1% suspension of fixed promastigotes
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was stained overnight with equal volume of 0.05% coomassie brilliant blue in saline citrate.
Subsequently, the stained promastigotes were washed with the saline citrate. One part of the
promastigotes was suspended in Antigen Stabilizing Solution (ASS) and the remainder in sa-
line citrate in 0.35% to 0. 4% concentrations and stored after filtration through nylon gauge.
1-ml aliquots of promastigotes, suspended in ASS, were freeze-dried and sealed under vacu-
um.Remaining AQ antigen was stored at 4°C for further use.
Particle loss on freeze-drying:
Particle loss on freeze drying was calculated by subtracting mean packed cell volume of
FD antigen from mean packed cell volume of AQ antigen which were determined by cen-
trifuging 10% promastigote suspension of AQ and FD antigen in graduated capillary tubes at
3000 rpm for 10 minutes. As the original column of promastigote suspension in the capillary
tube is 100 mmlong, the volume of packed cells can be expressed directly as a percentage.
Reconstitution of FD Antigen prior to use:
Each aliquot of FD antigen was reconstituted in 0.6 ml of normal saline (0.9% NaCl)
and kept at room temperature for 30 minutes before performing DAT.
Performance of the test:
DAT was carried out as per method of Harith et al, (1986) in V-shaped 96 well
microtitre plates. Serum samples were serially diluted (1:100 to 1:6553600) in 0.2% gelatin
(SIGMA Chemical Company, ST. Louis, USA) containing 0.9% NaCl (w/v) and 0.78% (v/v)
2-mercaptoethanol. 1:1600 serum dilutions were estimated to be the best cut off between
sensitivity an specificity. This parameter was exclusively based on results of cases from ac-
tive VL patients, endemic controls and from patients with other diseases. End point titre was
taken into consideration for comparing diagnostic potential of FD and AQ antigens. For
comparing FD and AQ antigen with rK39 strip test both the AQ and FD antigens were tested
at a cut off dilution of 1:1600. The end point was determined as the highest dilution at which
agglutination was still visible, as a blue mat, enlarged dot with frayed edges, or enlarged blue
dot, compared with negative control wells, which has clear blue dots.
rK39 Strip Test:
rK39 strips received from WHO were tested both with the neat serum samples as well
as with their 1:100 dilutions as described by Sundar et al. (1998).
Serum Samples:
A total of 708 serum samples comprising 86 parasitologically proven cases, 8 PKDL
(Post Kala-azar Dermal Leishmaniasis) cases, 43 successfully treated cases, 150 asymptomatic
endemic controls, 150 non-endemic controls and 271 cases (from non-endemic area) suffering
from other diseases namely AIDS (17), amoebiasis (20), echinococcosis (3),, filariasis (40),
giardiasis (15), hepatitis-B (ll), leprosy (63), malaria (41), neurocysticercosis (5), typhoid (5),'
trypanosomiasis (1), and tuberculosis (50) were included in the study.
Stability of AQ and FD antigens:
AQ<antigen was kept at 4°C, room temperature and at 37°C. FD Antigen, FD pool
positive and FD pool negative sera samples were stored at 4°C, 37°C and 56°C as recom-
mended by WHO (Jerne and Perry, 1956). The reactivity of AQ and FD antigen was tested at
intervals of 7 and 15 days respectively in order to establish their stability.
Statistical Analysis:
The Wilcoxon signed rank sum test (Altman, 1991) was used for comparing two groups
of paired observations. Comparison of two proportions was done by "Z" test (Zar, 1974).
Particle loss on freeze-drying and subsequent reconstitution:
A particle loss of 41.48% (±8. 45%) was observed upon freeze-drying the promastigote
suspension stored in ASS. Accordingly each aliquot of FD antigen was reconstituted in 0. 6
ml of normal saline to achieve an initial 0. 35% to 0. 4% promastigote concentration (25-30
million promastigotes per ml of the antigen, a concentration equivalent to concentration of
promastigotes in AQ antigen) and to attain comparable agglutination. If the FD antigen is
reconstituted in an initial volume of 1 ml, the promastigote concentration is lower than the
promastigote concentration in AQ antigen which results in difference in agglutination patterns
with AQ and FD antigen and therefore in reading of final results. Actual comparison of
results is thus possible only when particle loss during freeze-drying is taken into consideration
and further reconstitution of FD antigen is done accordingly. Earlier workers (Meredith et al,
1995, Oskam et al, 1996 and Zijlstra et al, 1997) have not reported such an observation. Our
observation, therefore, assumes significance in view of the fact that a certain percentage or
number of promastigotes are necessary for performing DAT (Meredith et al, 1995, Oskam et
al, 1996 and Zijlstra et al, 1997).
Cut off titre:
271 serum samples from different groups of subjects suffering from diseases other than
VL were tested to establish cut off dilution. Our results reveal that not a single case showed
positivity if cut off value is set at 1 : 1600, thus this dilution can be treated as a cut off di-
lution for testing both the FD as well as AQ antigen
Stability of the AQ and FD antigen:
The AQ antigen remained fully reactive for 9 months when stored at 4°C but deterio-
rated at 37°C after 3 weeks of storage which is in agreement with the reported findings
(Harith et al, 1988, Meredith et al, 1995). Since AQ antigen did not deteriorate at 4°C, it was
used as standard antigen in all comparative studies including stability, sensitivity and specif-
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icity.
The FD antigen was found stable at 4°C, 37°C and 56°C for 24 months period studied so
far. The freeze-dried pool positive and pool negative sera were also found to be stable at
56°C. This indicate the feasibility of its use in DAT even under adverse field conditions.
Comparative End point titres of Kala-azar sera samples in DAT with FD and
AQ antigens:
Results have been presented in Table 1. All serum samples were tested with both the
FD & AQ antigens. Out of 86 serum samples from Kala-azar active cases 83 serum samples
were tested positive with the FD and AQ antigens in DAT. Statistical analysis showed that
the end point titres of FD antigen were on the average 0.86 step dilution lower than AQ
antigen (p>0.01). At a cut off dilution of 1 : 1600 no difference in quality of agglutination
was observed in any case with both the antigens.
Table 1: Comparison of End Point Antibody Titres of Sera Sample
using the Freeze-Dried and Aqueous antigens
No. of serum Reciprocal Antibody Titre



































The end point was expressed as the highest dilution at which agglutination was
still visible, as a blue mat, enlarged dot with frayed edges, or enlarged blue dot,
compared with negative control wells, which shows clear blue dots.
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C omparative sensitivity and specificity of FD and AQ antigen and rK39 strips:
The results of the comparative evaluation from different groups of subjects are
presented in Table 2. Of 86 proven cases, 83 showed positive response by DAT, both with
FD & AQ antigens, whereas only 74 showed positivity with rK39 strips, representing a sen-
sitivity of 96.5% and 86% respectively (P<0.05). In all the 74 cases, rK39 strips showed
positivity, both with neat sera as well as with their 1:100 dilution. These cases were also
positive with DAT. Similarly all 3 cases that were negative with DAT were also negative
with rK39 strips. In PKDL cases, there was no significant difference in response with rK39
strips, AQ and FD antigen (P>0.05). Both DAT and rK39 strip tests were unable to distin-
guish between active VL and past treated cases because positive responses of 81% and 86
% respectively were observed in past treated cases (P<0.05). This indicated that these tests
were not capable of distinguishing between active, sub-clinical and past treated cases. It
corroborates earlier finding that high levels of anti-Leishmanial antibodies remain circulating
in blood for a long time even after completion of treatment (Oskam et al, 1996; Zijltra et al,
1998).
9 of the 150 healthy control subjects from the VL endemic area showed positive
response both with AQ and FD antigen whereas 24 cases were positive with rK39 strips thus
representing positivity of 6% and 16% respectively (P>0.05). None of the 150 subjects from
non-endemic area showed a positive response either by DAT or rK39 strip test. All 271 serum
samples from non endemic areas from patients suffering from diseases other than VL did not
show any cross reactivity, FD & AQ antigen and rK39 strips test thus representing 100%
specificity with each of test systems.
The FD antigen is, therefore, at par with AQ antigen and rK39 strip test in all respects.
The merits of strip test are that it is quick, suitable for use under field conditions, requires
a tiny amount of peripheral blood and no laboratory facilities, and is simple to carry out and
read. Singh et al. (1997) has reported 100% sensitivity with the strip test while the studies
conducted on European and African VL cases using rK39 strip test have shown only 71. 4%
and 60% sensitivity respectively (Jelinek et al 1999; Anon, 1999). It has also been reported
Table 2: Comparative performance of FD, AQ Antigen & rK39 Strips in the
diagnosis of VL (Total 708 cases)
No and (%) of cases found positive by






























that rK39 ELISA remains positive even after 24 months of treatment (Zijlstra et al, 1998). The
shortcomings associated with AQ DAT antigen have been overcome by development of FD
Antigen. In addition to it, FD antigen may be a better diagnostic tool in terms of commercial
viability and cost effectiveness. The major advantage of FD Antigen is that because of its
improved stability, the production of its large batches will facilitate reproducible results over
a longer period of time. The DAT, particularly with FD antigen, also appears to be simple,
easy to perform, highly sensitive and specific. It is, therefore, more suitable and economically
feasible for diagnosis of VL under adverse field conditions prevailing in endemic zones
around in many countries, like Sudan, Bangladesh, Nepal and India and in African countries
where most of the affected population is below poverty line.
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